Jim Simons’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
470,696
-1,467
-0.3% -$5.65K ﹤0.01% 2032
2025
Q4
$1.88M Sell
472,163
-43,302
-8% -$128K ﹤0.01% 1904
2025
Q3
$1.61M Buy
515,465
+20,502
+4% +$68.1K ﹤0.01% 2215
2025
Q2
$1.66M Sell
494,963
-8,400
-2% -$39.8K ﹤0.01% 2233
2025
Q1
$2.13M Sell
503,363
-3,800
-0.7% -$15.8K ﹤0.01% 1956
2024
Q4
$1.2M Sell
507,163
-21,000
-4% -$30.9K ﹤0.01% 2388
2024
Q3
$676K Sell
528,163
-10,000
-2% -$13.8K ﹤0.01% 2648
2024
Q2
$823K Sell
538,163
-4,500
-0.8% -$7.08K ﹤0.01% 2435
2024
Q1
$912K Sell
542,663
-7,200
-1% -$14.4K ﹤0.01% 2542
2023
Q4
$985K Sell
549,863
-5,900
-1% -$10.8K ﹤0.01% 2419
2023
Q3
$1.05M Sell
555,763
-4,980
-0.9% -$8.35K ﹤0.01% 2257
2023
Q2
$824K Sell
560,743
-10,920
-2% -$18.8K ﹤0.01% 2584
2023
Q1
$1.11M Sell
571,663
-10,300
-2% -$24.5K ﹤0.01% 2404
2022
Q4
$1.31M Sell
581,963
-14,900
-2% -$34.6K ﹤0.01% 2370
2022
Q3
$1.44M Sell
596,863
-25,365
-4% -$59.7K ﹤0.01% 2264
2022
Q2
$1.29M Sell
622,228
-22,535
-3% -$52.1K ﹤0.01% 2533
2022
Q1
$1.82M Buy
644,763
+38,100
+6% +$127K ﹤0.01% 2296
2021
Q4
$2.83M Sell
606,663
-57,901
-9% -$197K ﹤0.01% 1885
2021
Q3
$1.78M Sell
664,564
-36,899
-5% -$110K ﹤0.01% 2174
2021
Q2
$2M Sell
701,463
-51,590
-7% -$152K ﹤0.01% 2262
2021
Q1
$2.28M Buy
753,053
+77,894
+12% +$253K ﹤0.01% 2132
2020
Q4
$1.99M Buy
675,159
+75,501
+13% +$229K ﹤0.01% 2114
2020
Q3
$1.93M Buy
599,658
+200
+0% +$657 ﹤0.01% 2156
2020
Q2
$2M Buy
599,458
+127,800
+27% +$465K ﹤0.01% 2189
2020
Q1
$1.71M Buy
471,658
+2,320
+0.5% +$10.4K ﹤0.01% 2128
2019
Q4
$2.42M Buy
469,338
+200
+0% +$1.06K ﹤0.01% 2230
2019
Q3
$2.78M Buy
469,138
+27,561
+6% +$153K ﹤0.01% 2098
2019
Q2
$2.81M Buy
441,577
+50,800
+13% +$308K ﹤0.01% 2155
2019
Q1
$2.27M Buy
390,777
+9,403
+2% +$54.5K ﹤0.01% 2245
2018
Q4
$2.3M Sell
381,374
-97
-0% -$580 ﹤0.01% 2160
2018
Q3
$2.18M Buy
381,471
+4,262
+1% +$25.1K ﹤0.01% 2228
2018
Q2
$2.31M Buy
377,209
+23,709
+7% +$148K ﹤0.01% 2195
2018
Q1
$2.36M Buy
353,500
+23,200
+7% +$160K ﹤0.01% 2244
2017
Q4
$2.43M Buy
330,300
+14,295
+5% +$105K ﹤0.01% 2228
2017
Q3
$2.23M Buy
316,005
+25,152
+9% +$174K ﹤0.01% 2244
2017
Q2
$2.04M Buy
290,853
+20,613
+8% +$136K ﹤0.01% 2257
2017
Q1
$1.88M Buy
270,240
+13,240
+5% +$80.3K ﹤0.01% 2275
2016
Q4
$1.41M Buy
257,000
+9,900
+4% +$51.6K ﹤0.01% 2392
2016
Q3
$1.24M Buy
247,100
+11,800
+5% +$55.5K ﹤0.01% 2456
2016
Q2
$1.06M Buy
235,300
+12,700
+6% +$58.2K ﹤0.01% 2508
2016
Q1
$999K Buy
222,600
+5,400
+2% +$25.7K ﹤0.01% 2595
2015
Q4
$1.14M Buy
217,200
+18,620
+9% +$106K ﹤0.01% 2401
2015
Q3
$1.15M Buy
198,580
+1,880
+1% +$11.7K ﹤0.01% 2313
2015
Q2
$1.41M Buy
196,700
+26,512
+16% +$184K ﹤0.01% 2279
2015
Q1
$1.13M Buy
170,188
+49,288
+41% +$308K ﹤0.01% 2243
2014
Q4
$723K Buy
120,900
+36,800
+44% +$189K ﹤0.01% 2299
2014
Q3
$415K Buy
84,100
+7,300
+10% +$35.3K ﹤0.01% 2373
2014
Q2
$346K Sell
76,800
-18,797
-20% -$83.9K ﹤0.01% 2437
2014
Q1
$430K Sell
95,597
-37,803
-28% -$180K ﹤0.01% 2401
2013
Q4
$682K Sell
133,400
-44,262
-25% -$216K ﹤0.01% 2248
2013
Q3
$805K Sell
177,662
-73,206
-29% -$364K ﹤0.01% 2107
2013
Q2
$1.28M Buy
+250,868
New +$1.25M ﹤0.01% 1811

Other funds holding CPIX

Jim Simons's CPIX Position: Q1 2026 in Review

Jim Simons reduced its Cumberland Pharmaceuticals (CPIX) stake by 0.31% in Q1 2026, selling an estimated $5.65K and leaving 470,696 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Jim Simons first reported a position in CPIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.83M in Q4 2021. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Jim Simons held 470,696 shares of Cumberland Pharmaceuticals worth $1.53M as of Q1 2026.
  • Jim Simons sold 1,467 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $5.65K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2032 holding.
  • Jim Simons first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Jim Simons's Cumberland Pharmaceuticals position peaked at $2.83M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.